Serena Marchetti

Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With <i>TP53</i>-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months

Suzanne Leijen, Robin M.J.M. van Geel, Gabe S. Sonke et al. · Journal of Clinical Oncology · 2016 · 343 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in<i>in vitro</i>and<i>in vivo</i>pharmacokinetic studies employing Bcrp1−/−/Mdr1a/1b−/− (triple-knockout) and wild-type mice

Serena Marchetti, Nienke A. de Vries, Tessa Buckle et al. · Molecular Cancer Therapeutics · 2008 · 200 citations

Medicine, Pharmacokinetics, Pharmacology +17

Neurofunctional dopaminergic impairment in elderly after lifetime exposure to manganese

Roberto G. Lucchini, Stefano Guazzetti, Silvia Zoni et al. · NeuroToxicology · 2014 · 108 citations · Full text

Pharmacy, Neuroscience, Toxicology +14

The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel

Andrew K.L. Goey, Irma Meijerman, Hilde Rosing et al. · Clinical Pharmacokinetics · 2013 · 66 citations

Pharmacy, Pharmacokinetics, Pharmacology +5

Hepatocyte Growth Factor and Inducible Nitric Oxide Synthase Are Involved in Multidrug Resistance–Induced Angiogenesis in Hepatocellular Carcinoma Cell Lines

Nadia Lasagna, Ornella Fantappiè, Michela Solazzo et al. · Cancer Research · 2006 · 58 citations

Medicine, Oncology, Pharmacology +14